Contact this trialFirst, we need to learn more about you.
Procedure
GS-9911 +/− Zimberelimab for Solid Cancers
Recruiting1 awardPhase 1
New Haven, Connecticut
This trial is testing a new drug, GS-9911, alone and with another drug that helps the immune system fight cancer, in patients with advanced solid tumors. The goal is to find out if GS-9911 is safe and to determine the best dose to use.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service